Centiva Capital’s Vaxart VXRT Stock Holding History

Centiva Capital’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-38,563	Closed	-$37K	–	1878
2022 Q4	$37K	Buy	+38,563	New	+$54.5K	﹤0.01%	1261
2021 Q3	–	Sell	-27,385	Closed	-$205K	–	1638
2021 Q2	$205K	Buy	+27,385	New	+$191K	﹤0.01%	1210

Other funds holding VXRT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Centiva Capital's VXRT Position: Q1 2023 in Review

Centiva Capital sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 38,563 shares — an estimated $37K sold.

Centiva Capital first reported a position in VXRT in Q2 2021 and held it in 2 quarters. The position peaked at $205K in Q2 2021. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

Centiva Capital reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
Centiva Capital sold 38,563 Vaxart shares in Q1 2023, an estimated $37K.
Centiva Capital first reported a position in Vaxart in Q2 2021 and held it in 2 quarters.
Centiva Capital's Vaxart position peaked at $205K in Q2 2021.
109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.